Authors' reply to Borg and Thoning: "Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study"

Am J Clin Dermatol. 2021 Nov;22(6):903-904. doi: 10.1007/s40257-021-00640-5. Epub 2021 Oct 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cohort Studies
  • Humans
  • Interleukin Inhibitors
  • Interleukin-12
  • Interleukin-17
  • Interleukin-23
  • Pharmaceutical Preparations*
  • Psoriasis* / drug therapy
  • Retrospective Studies

Substances

  • Interleukin Inhibitors
  • Interleukin-17
  • Interleukin-23
  • Pharmaceutical Preparations
  • Interleukin-12